Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
We are performing a prospective, randomized, controlled trial of dopamine versus
norepinephrine for septic shock. The trial will enroll patients with suspected or documented
site of infection and having 2 out of the three SIRS criteria. Patients will also be
receiving standard of care, early-goal directed therapy including but not limited to fluid
resuscitation, appropriate and early antibiotics, source control and evaluation for
drotrecogin alpha where deemed appropriate, while being supported for septic shock.